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The Exposure-Dependent Effects of Aged
Secondhand Smoke on Endothelial Function
Paul F. Frey, MD, MPH,* Peter Ganz, MD,* Priscilla Y. Hsue, MD,* Neal L. Benowitz, MD,†
Stanton A. Glantz, PHD,‡ John R. Balmes, MD,§ Suzaynn F. Schick, PHD§
San Francisco, California
Objectives The aim of this study was to investigate whether exposure to a range of relatively low concentrations of aged
secondhand smoke (SHS), similar to those encountered commonly in the community, would impair endothelial
function in a concentration-dependent manner.
Background Exposure to SHS impairs endothelial function in humans. The concentration-dependent relationship for aged
SHS effects on endothelial function after an exposure of short duration is unknown.
Methods Thirty-three healthy nonsmokers were exposed to 1 of 2 low levels of aged SHS or to conditioned filtered air for
30 min. The primary end point was change in maximal percent brachial artery flow-mediated dilation after
exposure.
Results In a linear regression model for each increase in SHS exposure by 100 g/m3 respirable suspended particles,
the absolute maximal percent brachial artery flow-mediated dilation was reduced by 0.67%. We did not find
evidence of a threshold for the effect of SHS on flow-mediated dilation.
Conclusions Short-term exposure to real-world levels of aged SHS for 30 min resulted in a concentration-dependent de-
crease in endothelial function as measured by flow-mediated dilation. (J Am Coll Cardiol 2012;59:
1908–13) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2012.02.025n
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cSecondhand smoke (SHS) causes cardiovascular disease (1),
and bans on public smoking have led to rapid reductions in
myocardial infarctions (2,3). The Institute of Medicine
found “an increased risk . . . even at the lowest levels of
exposure” (4). One key mechanism of cardiovascular disease
is endothelial dysfunction (5). Experimental data indicate
substantial effects on endothelial function in response to
chronic SHS exposures (6–8) and in response to a single
short-term exposure at levels encountered in hospitality
venues (9). Smoke typically lingers and ages in public sites;
From the *Division of Cardiology, San Francisco General Hospital, San Francisco,
California; †Division of Clinical Pharmacology and Experimental Therapeutics,
University of California-San Francisco, San Francisco, California, ‡Division of
Cardiology, Department of Medicine, University of California-San Francisco, San
Francisco, California; and the §Division of Occupational and Environmental Med-
icine, Department of Medicine, University of California-San Francisco, San Fran-
cisco, California. Dr. Frey has received a post-doctoral research award for this study
from the Tobacco-Related Disease Research Program. Dr. Benowitz has served as a
paid consultant to pharmaceutical companies that are developing or market smoking
cessation medications and has been a paid expert witness in litigation against tobacco
companies. Dr. Schick and the operation of the exposure chamber and assays of
tobacco smoke biomarkers were supported by the Flight Attendants Medical Research
Institute Bland Lane Center of Excellence on Secondhand Smoke at the University
of California, San Francisco. All other authors have reported that they have no
relationships relevant to the contents of this paper to disclose.Manuscript received July 18, 2011; revised manuscript received February 10, 2012,
accepted February 14, 2012.aged smoke is more toxic to the respiratory epithelium, per
unit mass, than fresh SHS (10). We tested the hypothesis
that aged SHS impairs endothelial function across a range
of relatively low exposures encountered in the community.
Methods
We exposed healthy (no diabetes, hypertension, chronic
respiratory disease, kidney disease, coronary artery disease,
prior myocardial infarction, or heart failure) nonsmokers
(n  33) to aged SHS for 30 min. Subjects were lifelong
onsmokers 18 to 40 years old with no SHS exposure within
0 days by history and confirmed by a salivary cotinine level
10 ng/ml (11). Our experimental SHS exposures were
valuated by urinary cotinine before and 4 h after each study,
ith a limit of quantification 0.05 ng/ml (12).
We assigned subjects to 1 of 3 exposure levels of aged
HS generated the day the subjects were available: 1) smoke-free,
onditioned filtered air; 2) 100 g/m3 respirable suspended
particles (RSPs; typical of the homes of smokers or restau-
rants); or 3) 400 g/m3 RSPs (typical of smoky bars and
casinos) (1). Vascular studies were performed at baseline
and immediately after SHS exposure. Urinary high-
sensitivity cotinine levels were assessed at 0 and 4 h and
blood asymmetric dimethyl-L-arginine (ADMA) and
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SHS exposure. The study protocol was approved by the
University of California, San Francisco, Committee on
Human Research; all subjects gave written informed
consent.
SHS exposure. Marlboro Red hard-pack cigarettes were
smoked using a TE10-z smoking machine (Teague Enterprises,
Woodland, California). The smoke was diluted with filtered
air at 45% to 55% relative humidity and 20°C to 22.5°C,
aged for 60 min in a stainless steel chamber, and then routed
o the hood (Hood H-410-10/07037; 3M, St. Paul, Minne-
ota) for 30-min human exposure. Control exposures used
he same hood and purified air, free of smoke. RSP
oncentration was monitored continuously immediately up-
tream of the subject using a photometer (Dusttrak 8350,
SI Corporation, Shoreview, Minnesota). The range of
ndividual exposures appears in Figure 1.
Endothelium-dependent dilation of the brachial artery
as measured by high-resolution ultrasound (MicroMaxx,
onosite, Bothell, Washington) before and immediately
fter SHS exposure (13). Baseline diameter and blood flow
elocity of the brachial artery were quantified after 15 min of
upine rest in a dark, quiet room after an overnight fast. A
lood pressure cuff was placed on the forearm and inflated
o 200 mm Hg for 5 min. After cuff deflation, the
aximal increase in brachial artery end-diastolic diameter
as measured at 40, 60, 80, and 100 s using a digital analysis
ystem (Medical Imaging Applications, Iowa City, Iowa)
nd averaged over at least 3 consecutive cardiac cycles.
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Figure 1 Absolute Change in %FMDmax (Post-Exposure Minus P
The correlation coefficient (r) is 0.47. Solid circles  subject values, and the lin
%FMD  maximal percent brachial artery flow-mediated dilation; RSP  respiramaxBefore data analysis, the image
quality of 3 participants was
deemed insufficient by a blinded
investigator, and their flow-
mediated dilation (FMD) data
were excluded from further anal-
ysis, leaving 30 participants with
complete FMD data.
Maximal percent brachial artery
FMD (%FMDmax) was calculated
as: [(diametermax – diameterbaseline)/
diameterbaseline)]  100%. To ac-
ount for any differences from
ubject to subject in baseline %FM-
max, we also examined relative
change in %FMDmax. The absolute
and relative changes yielded similar
results. The images were measured
by a single investigator (P.F.F.)
blinded to the subject’s exposure
level. Plasma ADMA and symmetric dimethyl-L-arginine
SDMA) levels (14) and plasma free nitrotyrosine levels (15) were
easured by high-performance liquid chromatography (Ox-
nonon Inc., Emeryville, California).
tatistical analysis. Subjects’ baseline characteristics are
xpressed as mean  SD, and comparisons between expo-
ure groups were made using 1-way analysis of variance for
ontinuous variables and chi-square tests for categorical
ariables.
Abbreviations
and Acronyms
ADMA  asymmetric
dimethyl-L-arginine
FMD  flow-mediated
dilation
MED  minimal effective
dose
%FMDmax  maximal
percent brachial artery
flow-mediated dilation
%FMD0  baseline percent
brachial artery flow-
mediated dilation
RSPs  respirable
suspended particle
SDMA  symmetric
dimethyl-L-arginine
SHS  secondhand smoke
400 600
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Fitted values
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Secondhand Smoke and Endothelial Function May 22, 2012:1908–13We tested for a linear relationship between absolute and
relative change in %FMDmax and SHS exposure using linear
egression (Fig. 1). We also tested for evidence of a
hreshold or minimal effective dose (MED) of SHS by
tting a piecewise linear model (16) using nonlinear regres-
ion, in which FMD response was constant at some baseline
evel up to the MED, then increased linearly after that with
onlinear regression to estimate the baseline level (%FMD0),
ED, and slope above the MED (b):
%FMDmax%FMD0 if RSPsMED%FMD0 b(RSPsMED) if RSPsMED
This analysis did not produce evidence of a threshold effect,
so we used simple linear regression to quantify the relation-
ships between absolute and relative %FMDmax change and
RSPs.
To assess the influence of accepted risk factors of
impaired vascular function on FMD, we tested univariate
linear regressions of absolute change in %FMDmax
against age, sex, body mass index, total cholesterol,
baseline cotinine values, baseline arterial diameter, and
baseline %FMDmax.
To see if they were related to SHS exposure, we also
correlated changes in the biomarkers ADMA, SDMA,
nitrotyrosine, and high-sensitivity urinary cotinine (the
value at 4 h after exposure minus the value at time zero
before exposure) with SHS concentration using Spearman
rank-order correlations.
Results
Our subjects had few cardiovascular risk factors (Table 1),
with no significant differences among exposure groups.
Baseline mean brachial artery diameter was 3.79  0.74
mm. Baseline mean %FMDmax was 5.2  2.3%, similar
Baseline CharacteristicsTable 1 Baseline Characteristics
Characteristics
Control
(n  11)
Dose (g/m3 RSPs) 0
Men/women 5/6
Age (yrs) 24 2
BMI (kg/m2) 26.2 4.8
HbA1c 5.3 .0.4
Total cholesterol 158 26
High-density lipoprotein (mg/dl) 57 13
Low-density lipoprotein (mg/dl) 85 19
Triglycerides 71 30
Baseline artery diameter 3.79 0.9
Baseline SBP (mm Hg) 110 15
Baseline DBP (mm Hg) 72 8
Values aremean SD. *For analysis of variance or chi-square test (for
groups did not lead to significant differences in subject characteristicBMI body mass index; DBP diastolic blood pressure; HbA1c glycosyla
blood pressure.o previous adult study populations free of cardiovascu-
ar disease (17). The linear regression showed that
FMDmax decreased by 0.67% (95% confidence interval:
0.18 to 1.17, p  0.01) for each 100 g/m3 increase in
SHS (RSPs) (Fig. 1). Risk factors for impaired vascular
function (age, sex, body mass index, total cholesterol,
baseline cotinine values, and baseline arterial diameter)
were not significantly related to absolute changes in
%FMDmax (p  0.30) in this healthy population. Base-
ine %FMDmax was correlated with absolute change in
FMDmax (p  0.01). The analysis examining relative
change in %FMDmax similarly yielded a significant cor-
relation between SHS exposure and relative change in
%FMDmax (p  0.02) (Fig. 2).
otinine, ADMA, SDMA, and nitrotyrosine levels. The
edian urinary cotinine level at baseline before exposure
as 0.16 ng/ml (interquartile range: 0.07 to 0.85 ng/ml),
onsistent with nonsmokers without recent SHS exposure
18). As expected, there was a significant correlation be-
ween SHS exposure and change in urinary cotinine levels
h after exposure (p  0.02).
The mean nitrotyrosine levels for all participants were
5.7  7.3 nmol/l at baseline and 24.6  18.5 nmol/l 4 h
fter exposure. Nitrotyrosine levels increased after exposure
n all 3 groups, suggesting a circadian increase in nitroty-
osine in fasting subjects. There was no correlation between
he change in nitrotyrosine levels and SHS exposure level
p  0.99) (Table 2).
The mean baseline ADMA and SDMA levels for all
tudy participants were 0.44 0.09 mol/l and 0.48 0.10
mol/l, respectively, and levels obtained 4 h after exposure
were 0.44  0.09 mol/l and 0.48  0.10 mol/l, respec-
ively. There was no correlation between the change in
DMA from baseline to 4 h after exposure and the
oncentration of RSP (p 0.65), nor for SDMA (p 0.48)
Table 3).
Lowest Dose
(n  11)
Low Dose
(n  11) p Value*
142 39 392 77
6/5 6/5 0.24
25 4 29 7 0.08
23 2.3 23.7 3.2 0.12
5.3 0.4 5.3 0.4 0.89
157 21 152 33 0.85
58 14 50 11 0.40
90 21 88 28 0.92
73 45 67 25 0.90
3.73 0.62 3.84 0.75 0.95
106 10 107 11 0.69
67 6 70 10 0.40
. p Values illustrate that the allocation of subjects to different exposure
en exposure groups.gender)
s betweted hemoglobin; RSP respirable suspended particle; SBP systolic
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May 22, 2012:1908–13 Secondhand Smoke and Endothelial FunctionDiscussion
Our results demonstrate a concentration-dependent de-
crease in endothelium-dependent dilation of the brachial
artery after a single 30-min exposure to aged SHS, extend-
ing even to the low range of SHS concentrations: for each
increase in SHS exposure by 100 g/m3, the absolute
FMDmax was reduced by 0.67%.
We have extended to lower exposure concentrations the
findings of Heiss et al. (9), who demonstrated that 30-min
exposure to fresh SHS concentrations of 367  43 g/m3
resulted in an average absolute %FMDmax value reduction of
3%, comparable with the reduction in %FMDmax of 2.48%
at 367 g/m3 (95% confidence interval: 0.66% to 4.29%) we
ound.
Our findings are consistent with the epidemiological
ndings of the INTERHEART study (19), analyses of the
merican Cancer Society cohort (20), and meta-analyses
onducted by the U.S. Surgeon General’s Office on smoking
nd health (21). These studies showed a dose-response
elationship between exposure to SHS and the risk for
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Figure 2 Relative Change in %FMDmax (Post-Exposure Minus Pre-Ex
The correlation coefficient (r) is 0.44. Solid circles  subject values, and the lin
Effect of Exposure to Secondhand Smoke on SyTable 2 Effect of Exposure to Secondhand S
Nitrotyrosine Level (nmol/l)
Control
(n  11)
Baseline 14 (13–19)
Immediately after exposure 15 (13–17)
2 h after exposure 17.5 (13–22)
4 h after exposure 21 (13–35)Values are median (interquartile range). Nitrotyrosine values were not norm
analysis of variance on ranks.ardiovascular disease, with higher levels or longer exposures
eading to greater levels of risk. Epidemiological studies of
mbient particulate pollution have shown that decreases as
mall as 10 g/m3 annual average concentration of fine
particulate matter were associated with increased life expec-
tancy (22). This result is consistent with our observation of
no threshold for the effects of SHS on endothelial function.
Our research strengthens the evidence that SHS is detri-
mental to cardiovascular health even at very short exposures
and low particulate concentrations.
We hypothesized that 1 biologic pathway for the
endothelium-dependent dysfunction detected would be in-
creased degradation of endothelium-derived nitric oxide,
detected by elevated plasma nitrotyrosine levels, and by
increased accumulation of the competitive inhibitor of nitric
oxide synthesis ADMA. Our data did not support this
hypothesis. There was no statistical difference between
baseline nitrotyrosine, ADMA, and SDMA values and
values 4 h after exposure. Published data correlating tobacco
smoke exposure and ADMA levels have yielded conflicting
400 600
ndhand Smoke Exposure − (RSP µg/m3)
Fitted values
e) in Percent Versus Dose of SHS With Linear Regression Line
tted values by linear regression model. Abbreviations as in Figure 1.
ic Nitrotyrosine Levelse on Systemic Nitrotyrosine Levels
Lowest Dose
(n  11)
Low Dose
(n  11) p Value
12.5 (10–15) 12 (12–20) 0.54
12.5 (11–14) 13 (12–23) 0.47
17 (12–48) 14 (12–21) 0.63
18.5 (12–27) 17.5 (12–22) 0.80 Seco
s
posur
e  fistemmokally distributed, so they were analyzed using Kruskal-Wallis 1-way
mriance.
thyl-L-a
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sures (23–25).
Study limitations. Because we exposed subjects briefly to
low concentrations of SHS, it is possible that increases in
intracellular nitrotyrosine and ADMA in endothelial cells
were not large enough to spill over into systemic circulation
and be detected in plasma. Our sample size had power to
detect ADMA changes 0.22 mol/l. In daily life, non-
smokers may be exposed to SHS for much longer, and the
time course of change in ADMA and nitrotyrosine is not
known. Our subjects were at rest. During exercise, exposure
to SHS is higher because of increased minute ventilation.
Our subjects were healthy and may have been less suscep-
tible to decrements in endothelial function than patients
with vascular disease who are at greatest risk for SHS-
induced acute cardiovascular events.
Conclusions
Short-term exposure to low levels of SHS for 30 min results
in a concentration-dependent decrease in endothelial func-
tion, a key mechanism for all stages of atherosclerosis,
making policies to limit SHS exposure at low concentra-
tions important.
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